Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1995-05-30
1996-11-26
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514539, 514562, 514567, 514568, 558414, 560 17, 560 21, 560 43, 562431, 562435, 562454, 562456, 562457, A61K 31195, A61K 31215, A61K 31275
Patent
active
055786391
ABSTRACT:
Certain compounds have been synthesized and found to be effective inhibitors of phospholipase A.sub.2 (PLA.sub.2), and thereby useful in the treatment of intestinal cholesterol absorption and the disease states arising therefrom, such as hypercholesterolemia and coronary artery disease.
REFERENCES:
patent: 3573290 (1971-03-01), Sallmann et al.
patent: 3673243 (1972-06-01), Yamamoto et al.
patent: 5347036 (1994-09-01), Scherrer
J. Lipid Res., vol. 22, pp. 744-752 (1981), Rampone et al.
Lipids, vol. 15, pp. 395-400 (1980), Hollander et al.
J. Lipid Res., vol. 21, pp. 525-536 (1980), Beil et al.
Biochim. Biophys. Acta, vol. 486, pp. 500-510 (1977), Rampone et al.
Digestive Diseases, vol. 23, pp. 316-320 (1978), O'Connor et al.
"Inhibition of intestinal absorption of endogenous cholesterol is not sufficient to lower plasma cholesterol in hamsters and rats", H. Lengsfeld et al. [Date not available].
J. Lipid Res., vol. 34, pp. 377-395 (1993), Harwood et al.
Arch Intern Med., vol. 153, pp. 1345-1353 (1993), Dressman et al.
Atherosclerosis VIII, pp. 791-794 (1989), Kes aniemi et al.
Biochemistry, vol. 30, No. 42, pp. 10256-10268 (1991), Jain et al.
J. Med. Chem., vol. 35, No. 19, pp. 3584-3586 (1992), Jain et al.
Ashbrook Charles W.
Brust Joseph Paul
Warner-Lambert & Company
LandOfFree
PLA.sub.2 inhibitors and their use for inhibition of intestinal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PLA.sub.2 inhibitors and their use for inhibition of intestinal , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PLA.sub.2 inhibitors and their use for inhibition of intestinal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1973603